Primary Peritoneal Carcinoma
| Primary Site | Histology | Sex | 
|---|---|---|
| C481, C482, C488 | 8000-8700, 8720-8790, 8806, 8822, 8930-8931, 8933, 8950, 8960, 8980, 9000, 9050, 9052, 9060, 9070-9071, 9073, 9080, 9085, 9090-9091, 9100, 9110-9111 | 2, 6 | 
Notes
8000-8700, 8720-8790, 8806, 8822, 8930-8931, 8933, 8950, 8960, 8980, 9000, 9050, 9052, 9060, 9070-9071, 9073, 9080, 9085, 9090-9091, 9100, 9110-9111 (Sex: 2, 6) C481 Specified parts of peritoneum (female only) C482 Peritoneum (female only) C488 Overlapping lesion of retroperitoneum and peritoneum (female only) **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 55 *Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8000-8700, 8720-8790, 8822, 8933, 8950, 8960, 8980, 9000, 9050, 9052, 9060, 9070-9071, 9073, 9080, 9085, 9090-9091, 9100, 9110, 9700-9701 (Sex 1, 3, 5, 9): *Retroperitoneum* * 8710-8714, 8800-8803, 8810-8821, 8823-8921, 8932, 8934, 8940-8941, 8951-8959, 8963-8975, 8981-8990, 9010-9016, 9030-9043, 9045, 9051, 9053-9055, 9061-9065, 9072, 9081-9084, 9086, 9101-9105, 9120-9138, 9141-9230, 9240-9580, 9582: *Retroperitoneum* * 8804-8805, 8991-8992, 9020, 9044, 9231, 9581: *Soft Tissue Other* * 8806, 8930-8931 (Sex 1, 3, 5, 9): *Soft Tissue Other* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides*Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata | 
|---|---|---|---|---|---|
| Year of Diagnosis | No | 
                    NAACCR #390
                    
                         dateOfDiagnosis  | 
            
            
                None | ||
| Primary Site | Yes | 
                    NAACCR #400
                    
                         primarySite  | 
            
            
                None | ||
| Histology | Yes | 
                    NAACCR #522
                    
                         histologicTypeIcdO3  | 
            
            
                None | ||
| Behavior | Yes | 
                    NAACCR #523
                    
                         behaviorCodeIcdO3  | 
            
            
                None | ||
| Sex | Yes | 
                    NAACCR #220
                    
                         sex  | 
            
            
                None | ||
| Tumor Size Clinical | No | 
                    NAACCR #752
                    
                         tumorSizeClinical  | 
            
            
                None | ||
| Tumor Size Pathological | No | 
                    NAACCR #754
                    
                         tumorSizePathologic  | 
            
            
                None | ||
| Tumor Size Summary | 999 | No | 
                    NAACCR #756
                    
                         tumorSizeSummary  | 
            
            
                None | |
| Regional Nodes Positive | 99 | No | 
                    NAACCR #820
                    
                         regionalNodesPositive  | 
            
            
                None | |
| Regional Nodes Examined | 99 | No | 
                    NAACCR #830
                    
                         regionalNodesExamined  | 
            
            
                None | |
| RX Summ Surgery/Radiation Sequence | No | 
                    NAACCR #1380
                    
                         rxSummSurgRadSeq  | 
            
            
                None | ||
| RX Summ Systemic/Surgery Sequence | No | 
                    NAACCR #1639
                    
                         rxSummSystemicSurSeq  | 
            
            
                None | ||
| EOD Primary Tumor | 999 | Yes | 
                    NAACCR #772
                    
                         eodPrimaryTumor  | 
            
            
                None | |
| EOD Regional Nodes | 999 | Yes | 
                    NAACCR #774
                    
                         eodRegionalNodes  | 
            
            
                None | |
| EOD Mets | 00 | Yes | 
                    NAACCR #776
                    
                         eodMets  | 
            
            
                None | |
| SS2018 | No | 
                    NAACCR #764
                    
                         summaryStage2018  | 
            
            
                None | ||
| Grade Clinical | 9 | Yes | 
                    NAACCR #3843
                    
                         gradeClinical  | 
            
            
                All | SSDI | 
| Grade Pathological | 9 | Yes | 
                    NAACCR #3844
                    
                         gradePathological  | 
            
            
                All | SSDI | 
| Grade Post Therapy Clin (yc) | No | 
                    NAACCR #1068
                    
                         gradePostTherapyClin  | 
            
            
                COC NPCR SEER  | 
            
            SSDI | |
| Grade Post Therapy Path (yp) | No | 
                    NAACCR #3845
                    
                         gradePostTherapy  | 
            
            
                CCCR/Canada COC NPCR SEER  | 
            
            SSDI | |
| FIGO Stage | 98 | No | 
                    NAACCR #3836
                    
                         figoStage  | 
            
            
                COC SEER  | 
            
            SSDI | 
| CA-125 PreTx Interpretation | 8 | No | 
                    NAACCR #3818
                    
                         ca125PretreatmentInterpretation  | 
            
            
                CCCR/Canada COC SEER  | 
            
            SSDI | 
| Residual Tumor Volume Post Cytoreduction | 98 | No | 
                    NAACCR #3921
                    
                         residualTumVolPostCytoreduction  | 
            
            
                COC SEER  | 
            
            SSDI | 
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata | 
|---|---|---|---|---|
| Schema ID | 00552 | 
                    NAACCR #3800
                    
                         schemaId  | 
            
            None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 | 
                    NAACCR #762
                    
                         derivedSummaryStage2018  | 
            
            None | |
| Derived Summary Grade 2018 | <BLANK> | 
                    NAACCR #1975
                    
                         derivedSummaryGrade2018  | 
            
            None |